Sunflower Pharmaceutical Group Co.,Ltd (002737.SZ)
CNY 20.79
(0.43%)
CNY 20.79
(0.43%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 5.63 Billion | 5.09 Billion | 4.46 Billion | 3.46 Billion | 4.37 Billion | 4.47 Billion |
| Cost of Revenue | 2.55 Billion | 2.15 Billion | 1.81 Billion | 1.44 Billion | 1.81 Billion | 1.83 Billion |
| Gross Profit | 3.07 Billion | 2.94 Billion | 2.64 Billion | 2.01 Billion | 2.55 Billion | 2.64 Billion |
| Operating Expenses | 1.89 Billion | 1.83 Billion | 1.78 Billion | 1.23 Billion | 1.78 Billion | 1.94 Billion |
| Selling, General and Administrative Expenses | 1.78 Billion | 1.4 Billion | 1.29 Billion | 953.29 Million | 1.38 Billion | 1.56 Billion |
| Research and Development Expenses | 139.99 Million | 103.19 Million | 139.27 Million | 119.37 Million | 121.67 Million | 125.54 Million |
| Other Expenses | 6.81 Million | 322.96 Million | 351.22 Million | 157.87 Million | 271.4 Million | 4.65 Million |
| Cost and Expenses | 4.33 Billion | 3.98 Billion | 3.6 Billion | 2.67 Billion | 3.59 Billion | 3.78 Billion |
| Operating Income | 1.36 Billion | 1.08 Billion | 885.2 Million | 766.62 Million | 760.41 Million | 715.74 Million |
| Interest Expense | 6.34 Million | 9.72 Million | 10.18 Million | 7.39 Million | 12.13 Million | 6.49 Million |
| Income Tax Expense | 189.83 Million | 171.4 Million | 132.16 Million | 146.88 Million | 142.86 Million | 112.6 Million |
| Earnings before Tax | 1.35 Billion | 1.08 Billion | 894.51 Million | 766.82 Million | 777.97 Million | 720.4 Million |
| Net Income | 1.11 Billion | 867.22 Million | 704.73 Million | 584.45 Million | 565.42 Million | 563.27 Million |
| Earnings Per Share Basic | 1.92 | 1.48 | 1.21 | 1.01 | 0.97 | 0.96 |
| Earnings Per Share Diluted | 1.92 | 1.48 | 1.21 | 1.01 | 0.97 | 0.96 |
| Weighted Average Shares Outstanding | 582.88 Million | 584 Million | 581.04 Million | 576.86 Million | 582.9 Million | 584 Million |
| Weighted Average Shares Outstanding (Diluted) | 582.88 Million | 584 Million | 581.04 Million | 576.86 Million | 582.9 Million | 586.74 Million |
| Gross Margin | 0.55 | 0.58 | 0.59 | 0.58 | 0.59 | 0.59 |
| EBIT Margin | 0.27 | 0.27 | 0.24 | 0.28 | 0.22 | 0.19 |
| Profit Margin | 0.20 | 0.17 | 0.16 | 0.17 | 0.13 | 0.13 |
| EBITDA | 1.54 Billion | 1.36 Billion | 1.07 Billion | 923.37 Million | 941.24 Million | 873 Million |
| Earnings Before Tax Margin | 0.24 | 0.21 | 0.20 | 0.22 | 0.17 | 0.16 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 439.3 Million | 995.33 Million | 1.5 Billion | 1.44 Billion | 5.63 Billion | 1.2 Billion |
| Cost of Revenue | 297.53 Million | 477.06 Million | 656.36 Million | 738.77 Million | 2.55 Billion | 528.23 Million |
| Gross Profit | 141.77 Million | 518.26 Million | 845.69 Million | 705.71 Million | 3.07 Billion | 673.03 Million |
| Operating Expenses | 34.52 Million | 243.58 Million | 541.78 Million | 484.86 Million | 1.89 Billion | 461.31 Million |
| Selling, General and Administrative Expenses | 317.81 Million | 218.33 Million | 516.93 Million | 452.46 Million | - | 592.68 Million |
| Research and Development Expenses | 27.99 Million | 26.11 Million | 22.99 Million | 31.25 Million | - | 43.76 Million |
| Other Expenses | -311.28 Million | 867.04 Thousand | -1.85 Million | -1.13 Million | 6.81 Million | 9.27 Million |
| Cost and Expenses | 332.05 Million | 720.65 Million | 1.19 Billion | 1.22 Billion | 4.45 Billion | 989.55 Million |
| Operating Income | 104.08 Million | 274.68 Million | 303.9 Million | 220.85 Million | 1.18 Billion | 226.55 Million |
| Interest Expense | 1.26 Million | 150.62 Thousand | 203.49 Thousand | 1.5 Million | 5.96 Million | 430.69 Thousand |
| Income Tax Expense | 14.93 Million | 56.59 Million | 67.31 Million | 40.59 Million | 189.83 Million | 12.3 Million |
| Earnings before Tax | 104.16 Million | 302.94 Million | 338.08 Million | 318.97 Million | 1.35 Billion | 220.45 Million |
| Net Income | 100.5 Million | 231.14 Million | 255.18 Million | 267.95 Million | 1.11 Billion | 213.02 Million |
| Earnings Per Share Basic | 0.17 | 0.40 | 0.44 | 0.46 | - | 0.36 |
| Earnings Per Share Diluted | 0.17 | 0.40 | 0.44 | 0.46 | - | 0.36 |
| Weighted Average Shares Outstanding | 584 Million | 584 Million | 584 Million | 584 Million | 584 Million | 584 Million |
| Weighted Average Shares Outstanding (Diluted) | 584 Million | 584 Million | 584 Million | 584 Million | 584 Million | 591.73 Million |
| Gross Margin | 0.32 | 0.52 | 0.56 | 0.49 | 0.55 | 0.56 |
| EBIT Margin | 0.24 | 0.32 | 0.23 | 0.18 | - | 0.19 |
| Profit Margin | 0.23 | 0.23 | 0.17 | 0.19 | 0.20 | 0.18 |
| EBITDA | 105.43 Million | 319.8 Million | 348.03 Million | 257.83 Million | - | 230.35 Million |
| Earnings Before Tax Margin | 0.24 | 0.28 | 0.20 | 0.15 | 0.21 | 0.19 |
300376
SRI
CCC
4263
8300
0JDK